As news flows in from Beijing that a Chinese research firm has become the first organisation to enter phase II of clinical trials in the global race to find a vaccine for the coronavirus, India, too, is gearing up to develop its indigenous variant soon. With vaccines of some firms already in the animal trial … Read more
Bharat Biotech is getting into development and testing of a vaccine against COVID-19 called CoroFlu as part of an international collaboration of virologists and vaccine makers. CoroFlu is a one drop COVID-19 nasal vaccine built on a flu vaccine “backbone” that has been shown to be safe and well-tolerated in humans, in Phase I and … Read more
In a positive for Biocon, US drug regulator USFDA has accepted a biologics licence application by biopharmaceutical major and partner Mylan for a proposed biosimilar to treat advanced colon or rectal cancer. The application seeks approval of biosimilar bevacizumab for treatment of patients with metastatic colorectal cancer in addition to other ailments. “Once approved, our … Read more
Healthcare startup Qure.ai has raised $16 million in an equity funding round led by Sequoia India, with participation from MassMutual Ventures Southeast Asia, it said Thursday. MassMutual Ventures is the investment arm of US-based MassMutual Life Insurance Company. Founded in 2016 by Prashant Warier and Pooja Rao, Qure.ai provides interpretations of radiology scans within seconds, … Read more
4th note in the series… the last one for calendar year 2019 !
Reports indicate that Reliance Life Sciences (RLS) is considering a foray into India’s medical diagnostics testing industry estimated at $10bn. Current capacities are claimed to be under-utilised in the diagnostic industry. As per Dr. A Velumani (CMD, Thyrocare), around 95 per cent of the laboratories are working under capacity, with machines lying idle. He believes … Read more